Insight Molecular Diagnostics (IMDX) Revenue Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 91.39% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 6.18% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 3.66% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.26% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 10.01% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 38.82% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 8.41% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 4.80% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 7.17% |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | -98.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.50% |
| Dec 31, 2025 | -23.35% |
| Sep 30, 2025 | 126.09% |
| Jun 30, 2025 | 398.08% |
| Mar 31, 2025 | 1,114.77% |
| Dec 31, 2024 | 373.25% |
| Sep 30, 2024 | -73.19% |
| Jun 30, 2024 | -77.54% |
| Mar 31, 2024 | -40.74% |
| Dec 31, 2023 | 14.60% |
| Sep 30, 2023 | 540.30% |
| Jun 30, 2023 | 95.36% |
| Mar 31, 2023 | -21.84% |
| Dec 31, 2022 | -92.37% |
| Sep 30, 2022 | -93.19% |
| Jun 30, 2022 | -88.33% |
| Mar 31, 2022 | -66.19% |
| Dec 31, 2021 | 613.52% |
| Sep 30, 2021 | 77.30% |
| Jun 30, 2021 | 1,319.58% |